Mitoxantrone: all 172 studies that test it

Page 2 of 2. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast CancerStatus unknownNCT02596373Phase 2
• Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid LeukemiaCompletedNCT02573363Phase 1
• Phase I Study of Mitoxantrone Hydrochloride Liposome InjectionStatus unknownNCT02131688Phase 1
• Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02070458Phase 1
• Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome InjectionCompletedNCT02043756Phase 1
• Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersStatus unknownNCT02021825Phase 4
• Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01904643Phase 1
• Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute LeukemiaCompletedNCT01842672Phase 1/2
• Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid LeukemiaCompletedNCT01839240Phase 1
• Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid LeukemiaTerminatedNCT01801046Phase 1
• CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01768897Phase 1
• Lenalidomide Plus Chemotherapy for AMLCompletedNCT01681537Phase 1
• Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in CombinationStatus unknownNCT01627938Phase 2
• Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate CancerCompletedNCT01594918Phase 1
• Vorinostat Plus FND in Relapsed or Refractory Mantle Cell LymphomaTerminatedNCT01578343Phase 2
• Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular LymphomaCompletedNCT01523860Phase 2
• Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaCompletedNCT01403415Phase 1
• Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid LeukemiaTerminatedNCT01260714Phase 1
• Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01249430Phase 1
• Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)CompletedNCT01186640Phase 2
• Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01127009Phase 1
• IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)TerminatedNCT01027923Phase 1
• Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00967057Phase 3
• Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaCompletedNCT00940524Phase 1
• Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasTerminatedNCT00882076Phase 1
• Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive LymphomasCompletedNCT00842595Phase 2
• Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid LeukemiaTerminatedNCT00660036Phase 1
• Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00627354Phase 2
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00470197Phase 1
• Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate CancerTerminatedNCT00447473Phase 2
• Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)CompletedNCT00408278Phase 4
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaCompletedNCT00337246Phase 2
• A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)CompletedNCT00304291Phase 4
• Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00274963Phase 2
• Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple SclerosisTerminatedNCT00219908Phase 2
• Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell LymphomaTerminatedNCT00183989Phase 2
• Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate CancerCompletedNCT00182741Phase 2
• Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's LymphomaCompletedNCT00169208Phase 2
• Study Evaluating Mitoxantrone in Multiple SclerosisTerminatedNCT00146159Phase 3
• Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)CompletedNCT00143975Phase 2
• Chemotherapy Followed by Zevalin for Relapsed Mantle Cell LymphomaCompletedNCT00119730Phase 2
• A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 YearsCompletedNCT00079105Phase 2
• Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus MitoxantroneCompletedNCT00059631Phase 1
• Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate CancerCompletedNCT00058084Phase 2
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00053131Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaCompletedNCT00047021Phase 2
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute LeukemiaCompletedNCT00016016Phase 1/2
• Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic CancersCompletedNCT00015951Phase 2
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005847Phase 2
• Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate CancerCompletedNCT00004071Phase 2/3
• Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for RecurrenceWithdrawnNCT00003858Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Prostate CancerStatus unknownNCT00003633Phase 1
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous LeukemiaWithdrawnNCT00003405Phase 2
• Chemotherapy in Treating Patients Who Have Metastatic Prostate CancerCompletedNCT00003343Phase 3
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian CancerCompletedNCT00003297Phase 1/2
• Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate CancerCompletedNCT00003232Phase 3
• Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate CancerStatus unknownNCT00003183Phase 1/2
• High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast CancerCompletedNCT00003068Phase 2
• Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous LeukemiaCompletedNCT00003003Phase 1
• Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaCompletedNCT00002912Phase 1
• Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
• Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial CancerTerminatedNCT00002819Phase 3
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002805Phase 2
• Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaStatus unknownNCT00002688Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002674Phase 2
• Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002598Phase 2
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedNCT00002565Phase 3
• Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast CancerCompletedNCT00002544Phase 3
• Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast CancerStatus unknownNCT00002498Phase 2
• Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian CancerCompletedNCT00002474Phase 2
• Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's SarcomaCompletedNCT00002259Phase 2
• Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasCompletedNCT00002003Phase 2

← Mitoxantrone overview